Chronic inflammatory disease of the respiratory system and recurrent exacerbations are mainly caused by damage to the immune regulation mechanisms [1]. In this study treatment of chronic inflammatory diseases of the respiratory tract in children and adults was carried out by combining a complementary therapy using MNRI®, based on activation of the primary motor system in addition to the traditional treatment [2].
Observation cohorts involved 196 children (2–13 years) and 94 adults (20–60 years) with chronic inflammatory and atopic diseases with concomitant obstructive bronchitis syndrome.
They first underwent in-patient and out-patient treatment in clinical hospitals in Poland and Russia, then underwent MNRI®. Control for the immune-modulating effect of the MNRI® program was a children’s group (15 children of the same age) suffering from respiratory obstructive bronchitis (ROB) and receiving conventional treatment only.
